Skip to main content
. 2019 Aug 14;13:2843–2852. doi: 10.2147/DDDT.S148654

Figure 2.

Figure 2

Percent change in spine bone mineral density (BMD) between subjects randomized to denosumab or bisphosphonate therapy.